Abstract
Human type 1 diabetes results from the selective destruction of insulin-producing pancreatic beta cells during islet inflammation. Cytokines and reactive radicals released during this process contribute to beta-cell death. Here we show that mice with a disrupted gene coding for poly (ADP-ribose) polymerase (PARP–/– mice) are completely resistant to the development of diabetes induced by the beta-cell toxin streptozocin. The mice remained normoglycemic and maintained normal levels of total pancreatic insulin content and normal islet ultrastructure. Cultivated PARP–/– islet cells resisted streptozocin-induced lysis and maintained intracellular NAD+ levels. Our results identify NAD+ depletion caused by PARP activation as the dominant metabolic event in islet-cell destruction, and provide information for the development of strategies to prevent the progression or manifestation of the disease in individuals at risk of developing type 1 diabetes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Simone, E. & Eisenbarth, G.S. Chronic autoimmunity of type I diabetes. Horm. Metab. Res. 28, 332– 336 (1996).
Kolb, H. et al. Essential contribution of macrophages to islet cell destruction in vivo and in vitro. J. Autoimmunity 3 (Suppl.), 117–120 (1990).
Kröncke, K.-D., Kolb-Bachofen, V., Berschick, B., Burkart, V. & Kolb, H. Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem. Biophys. Res. Commun. 175, 752– 758 (1991).
Steiner, L., Kröncke, K.-D., Fehsel, K. & Kolb-Bachofen, V. Endothelial cells as cytotoxic effector cells: cytokine activated rat islet endothelial cells lyse syngeneic islet cells via nitric oxide. Diabetologia 40, 150–155 (1997).
Corbett, J.A., Wang, J.L., Sweetland, M.A., Lancaster, J.R. & McDaniel, M.L. IL-1β induces the formation of nitric oxide by β-cells purified from rodent islets of Langerhans: evidence for the β-cell as a source and site of action of nitric oxide. J. Clin. Invest. 90, 2384– 2391 (1992).
Suarez-Pinzon, W.L., Strynadka, K., Schulz, R. & Rabinovitch, A. Mechanisms of cytokine-induced destruction of rat insulinoma cells: the role of nitric oxide. Endocrinology 134, 1006 –1010 (1994).
McDaniel, M.L., Kwon, G., Hill, J.R., Marshall, C.A. & Corbett, J.A. Cytokines and nitric oxide in islet inflammation. Proc. Soc. Exp. Biol. Med. 211, 24– 32 (1996).
Fehsel, K. et al. Islet cell DNA is a target of inflammatory attack by nitric oxide. Diabetes 42, 496– 500 (1993).
Kolb, H. Mouse models of insulin-dependent diabetes - Low dose streptozotocin induced diabetes and non obese diabetic (NOD) mice. Diabetes Metab. Rev. 3, 751–778 (1987).
Schnedl, W.J., Ferber, S., Johnson, J. & Newgard, C.B. STZ transport and cytotoxicity: Specific enhancement in GLUT2-expressing cells. Diabetes 43, 1326–1333 ( 1994).
Yamamoto, H., Uchigata, Y. & Okamoto, H. Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose)synthetase in pancreatic islets. Nature 294, 284–286 (1981).
Turk, J., Corbett, J.A., Ramanadham, S., Bohrer, A. & McDaniel, L. Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem. Biophys. Res. Commun. 197, 1458– 1464 (1993).
Kröncke, K.-D., Fehsel, K., Sommer, A., Rodriguez, M.-L. & Kolb-Bachofen, V. Nitric oxide generation during cellular metabolization of the diabetogenic N-methyl-N-nitroso-urea streptozotocin contributes to islet cell DNA damage. Biol. Chem. 376 , 179–185 (1995).
Yamada, K. et al. Preventive and therapeutic aspects of large dose nicotinamide injections on diabetes associated with insulitis: an observation in non-obese diabetic (NOD) mice. Diabetes 31, 749– 753 (1982).
Lazarus, S. & Shapiro, S. H. Influence of nicotinamide and pyridine nucleotides on streptozotocin and alloxan induced pancreatic B cell cytotoxicity. Diabetes 22, 499– 506 (1973).
Sestelli, P. et al. Structural requirements for inhibitors of poly(ADP-ribose)polymerase. J. Cancer Res. Clin. Oncol. 116, 615– 622 (1990).
Wang, Z.-Q. et al. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev. 9, 509–520 (1995).
Cardinal, J.W., Allan, D.J. & Cameron, D.P. Differential metabolite accumulation may be the cause of strain differences in sensitivity to streptozotocin-induced β cell death in inbred mice. Endocrinology 139, 2885–2891 (1998).
Leist, M., Single, B., Castoldi, A.F., Kühnle, S. & Nicotera, P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185, 1481– 1486 (1997).
Kallmann, B., Burkart, V., Krüncke, K.-D., Kolb-Bachofen, V. & Kolb, H. Toxicity of chemically generated nitric oxide towards pancreatic islet cells can be prevented by nicotinamide. Life Sci. 51, 671– 678 (1992).
Radons, J. et al. Nitric oxide toxicity in islet cells involves poly(ADP-ribose) polymerase activation and concomitant NAD+ depletion. Biochem. Biophys. Res. Commun. 199, 1270– 1277 (1994).
Heller, B. et al. Inactivation or the poly(ADP-ribose)polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J. Biol. Chem. 270, 11176–11180 ( 1995).
Eliasson, M. J. et al. Poly(ADP-ribose)polymerase gene disruption renders mice resistant to cerebral ischemia. Nature Med. 3, 1089–1095 (1997).
Zhang, J., Dawson, V.L., Dawson, T.M. & Snyder, S. H. Nitric oxide activation of poly(ADP-ribose)synthetase in neurotoxicity. Science 263, 687–689 ( 1994).
Thiemermann, C., Bowes, J., Myint, F.P. & Vane, J. R. Inhibition of the activity of poly(ADP-ribose)synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc. Natl. Acad. Sci. USA 94, 679–683 (1997).
Berger, N.A. Poly(ADP-ribose) in the cellular response to DNA damage. Radiat. Res. 101, 4–15 ( 1985).
Eguchi, Y., Shimizu, S. & Tsujimoto, Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 57, 1835 –1840 (1997).
Rosenthal, D. S. et al. Intact cell evidence for the early synthesis, and subsequent late apopain-mediated suppression, of poly(ADP-ribose) during apoptosis. Exp. Cell Res. 232, 313–321 (1997).
Simbulan-Rosenthal, C.M., Rosenthal, D.S., Iyer, S., Boulares, A.H. & Smulson, M.E. Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose)polymerase in the early stages of apoptosis. J. Biol. Chem. 273, 13703– 13712 (1998).
Wang, Z.-Q. et al. PARP is important for genomic stability but dispensable in apoptosis. Genes Dev. 11, 2347– 2358 (1997).
Ménissier de Murcia, J. et al. Requirement of poly(ADP-ribose)polymerase in recovery from DNA damage in mice and in cells. Proc. Natl. Acad. Sci. USA 94, 7303–7307 ( 1997).
Endres, M., Wang, Z.Q., Namura, S., Waeber, C. & Moskowitz, M.A. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J. Cereb. Blood Flow Metab. 17, 1143–1151 (1997).
Eizirik, D.L., Sandler, S., Sener, A. & Malaisse, W.J. Defective catabolism of D-glucose and L-glutamine in mouse pancreatic islets maintained in culture after streptozotocin exposure. Endocrinol. 123, 1001–1007 (1988).
Rasschaert, J., Eizirik, D.L. & Malaisse, W.J. Long term in vitro effects of streptozotocin, interleukin-1, and high glucose concentration on the activity of mitochondrial dehydrogenases and the secretion of insulin in pancreatic islets. Endocrinol. 130, 3522–3528 (1992).
LeDoux, S.P., Hall, C.R., Forbes, P.M., Patton, N.J. & Wilson, G.L. Mechanisms of nicotinamide and thymidine protection from alloxan and streptozotocin toxicity. Diabetes 37, 1015–1019 (1988).
Delaney, C.A., Green, M.H.L., Lowe, J.E. & Green, I.C. Endogenous nitric oxide induced by interleukin-1b in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the 'comet' assay. FEBS Lett. 333, 291– 295 (1993).
Burkart, V. et al. Low dose streptozotocin-induced diabetes in mice: Reduced IL-2 production and modulation of streptozotocin induced hyperglycemia by IL-2. Int. J. Immunopharmac. 14, 1037– 1044 (1992).
Appels, B. et al. Spontaneous cytotoxicity of macrophages against pancreatic islet cells. J. Immunol. 142, 3803– 3808 (1989).
Acknowledgements
We thank W. Fingberg for technical assistance, H. Jahr for support in determining pancreatic insulin contents, W. Waldhäusl and S. Baumgartner-Parzer for conducting blood glucose measurements, J. Friemann for support in the morphometrical studies and W.L. Gai for analysis of GLUT-2 mRNA expression. This work was supported by the Deutsche Forschungsgemeinschaft, the Bundesminister für Gesundheit and by the Minister für Wissenschaft und Forschung des Landes Nordrhein-Westfalen. L.S. and E.F.W. were partially supported by the Austrian Industrial Research Promotion Fund. Z.H. is in receipt of a Special Training Award from the International Agency for Research on Cancer (IARC).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Burkart, V., Wang, ZQ., Radons, J. et al. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat Med 5, 314–319 (1999). https://doi.org/10.1038/6535
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/6535
This article is cited by
-
Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies
Signal Transduction and Targeted Therapy (2023)
-
Role of poly(ADP-ribose) polymerase-1 in regulating human islet cell differentiation
Scientific Reports (2022)
-
Increased PARylation impacts the DNA methylation process in type 2 diabetes mellitus
Clinical Epigenetics (2021)
-
NMR-based metabolomics characterizes metabolic changes in different brain regions of streptozotocin-induced diabetic mice with cognitive decline
Metabolic Brain Disease (2020)
-
Congenic mapping and candidate gene analysis for streptozotocin-induced diabetes susceptibility locus on mouse chromosome 11
Mammalian Genome (2018)